Log in | Register

Aerosol therapy during mechanical ventilation: an international survey

Stephan Ehrmann| Ferran Roche-Campo| Giuseppe Francesco Sferrazza Papa| Daniel Isabey| Laurent Brochard| Gabriela Apiou-Sbirlea
Original
Volume 39, Issue 6 / June , 2013

Pages 1048 - 1056

Abstract

Purpose

To describe the practice, knowledge and beliefs about aerosol therapy during mechanical ventilation in an international sample of physicians working in intensive care units (ICU).

Methods

A self-administered survey was emailed to physicians who worked regularly in ICUs. The physicians were identified from the databases of the European and French societies of intensive care medicine and the REVA network.

Results

Of the 1,192 responses (15 % response rate), 854 were analyzed. Of the respondents, who represented 611 departments in 70 countries, 99 % reported using aerosol therapy during mechanical ventilation (including non-invasive), 43 % exclusively used nebulizers and 55 % also used metered dose inhalers. Nebulization relied on jet, ultrasonic and vibrating mesh nebulizers (55 %, 44 % and 14 % of respondents, respectively). Bronchodilators and steroids were the most frequently delivered drugs, and 80 % of respondents had a positive opinion concerning nebulized colistin and 30 % reported the use of nebulized antibiotics at least every other month. During nebulization, ventilator settings were never changed by 77 % of respondents, 65 % reported placing a filter on the expiratory limb, and of these 28 % never changed it. Only 22 % of respondents using heated humidifiers reported turning them off during nebulization. Specific knowledge about droplet size and nebulization yield was poor. A majority of respondents (87 %) thought that ultrasonic nebulizers outperform jet nebulizers, while 69 % had no opinion concerning mesh nebulizers.

Conclusions

Aerosol therapy during mechanical ventilation is used by over 95 % of intensivists, mostly for bronchodilator and steroid administration, but also frequently for antibiotics. The current scientific knowledge about optimal implementation seemed infrequently applied, suggesting the need for educational programs and research focusing on a better bench-to-bedside transfer of knowledge.

Keywords

References

  1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532–555
    • View reference on PubMed
    • View reference on publisher's website
  2. Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, Schidlow DV, Wilmott RW, Astley SJ, McBurnie MA (1993) Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 328:1740–1746
    • View reference on PubMed
    • View reference on publisher's website
  3. Hess D (1990) The delivery of aerosolized bronchodilator to mechanically ventilated intubated adult patients. Respir Care 35:399–404
  4. Fuller HD, Dolovich MB, Posmituck G, Pack WW, Newhouse MT (1990) Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs. Am Rev Respir Dis 141:440–444
    • View reference on PubMed
    • View reference on publisher's website
  5. MacIntyre NR, Silver RM, Miller CW, Schuler F, Coleman RE (1985) Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med 13:81–84
    • View reference on PubMed
    • View reference on publisher's website
  6. O’Riordan TG, Greco MJ, Perry RJ, Smaldone GC (1992) Nebulizer function during mechanical ventilation. Am Rev Respir Dis 145:1117–1122
    • View reference on PubMed
    • View reference on publisher's website
  7. Diot P, Morra L, Smaldone GC (1995) Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med 152:1391–1394
    • View reference on PubMed
    • View reference on publisher's website
  8. Fink JB, Dhand R, Grychowski J, Fahey PJ, Tobin MJ (1999) Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors. Am J Respir Crit Care Med 159:63–68
    • View reference on PubMed
    • View reference on publisher's website
  9. Miller DD, Amin MM, Palmer LB, Shah AR, Smaldone GC (2003) Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am J Respir Crit Care Med 168:1205–1209
    • View reference on PubMed
    • View reference on publisher's website
  10. Dhand R (2008) Aerosol delivery during mechanical ventilation: from basic techniques to new devices. J Aerosol Med Pulm Drug Deliv 21:45–60
    • View reference on PubMed
    • View reference on publisher's website
  11. Guerin C, Fassier T, Bayle F, Lemasson S, Richard JC (2008) Inhaled bronchodilator administration during mechanical ventilation: how to optimize it, and for which clinical benefit? J Aerosol Med Pulm Drug Deliv 21:85–96
    • View reference on PubMed
    • View reference on publisher's website
  12. Rau JL, Harwood RJ, Groff JL (1992) Evaluation of a reservoir device for metered-dose bronchodilator delivery to intubated adults. An in vitro study. Chest 102:924–930
    • View reference on PubMed
    • View reference on publisher's website
  13. Goldstein I, Wallet F, Robert J, Becquemin MH, Marquette CH, Rouby JJ (2002) Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs. Am J Respir Crit Care Med 165:171–175
    • View reference on PubMed
    • View reference on publisher's website
  14. Goldstein I, Wallet F, Nicolas-Robin A, Ferrari F, Marquette CH, Rouby JJ (2002) Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets. Am J Respir Crit Care Med 166:1375–1381
    • View reference on PubMed
    • View reference on publisher's website
  15. Palmer LB, Smaldone GC, Chen JJ, Baram D, Duan T, Monteforte M, Varela M, Tempone AK, O’Riordan T, Daroowalla F, Richman P (2008) Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 36:2008–2013
    • View reference on PubMed
    • View reference on publisher's website
  16. Ehrmann S, Mercier E, Vecellio L, Ternant D, Paintaud G, Dequin PF (2008) Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects. Intensive Care Med 34:755–762
  17. Lu Q, Yang J, Liu Z, Gutierrez C, Aymard G, Rouby JJ (2011) Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med 184:106–115
    • View reference on PubMed
    • View reference on publisher's website
  18. Dhand R (2004) New frontiers in aerosol delivery during mechanical ventilation. Respir Care 49:666–677
    • View reference on PubMed
  19. Dhand R (2012) Aerosol therapy in patients receiving noninvasive positive pressure ventilation. J Aerosol Med Pulm Drug Deliv 25:63–78
    • View reference on PubMed
    • View reference on publisher's website
  20. Plaza V, Sanchis J, Roura P, Molina J, Calle M, Quirce S, Viejo JL, Caballero F, Murio C (2012) Physicians’ knowledge of inhaler devices and inhalation techniques remains poor in Spain. J Aerosol Med Pulm Drug Deliv 25:16–22
    • View reference on PubMed
    • View reference on publisher's website
  21. Burns KEA, Duffett M, Kho ME, Meade MO, Adhikari NKJ, Sinuff T, Cook DJ (2008) A guide for the design and conduct of self-administered surveys of clinicians. CMAJ 179:245–252
    • View reference on PubMed
    • View reference on publisher's website
  22. Kofteridis DP, Alexopoulou C, Valachis A, Maraki S, Dimopoulou D, Georgopoulos D, Samonis G (2010) Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study. Clin Infect Dis 51:1238–1244
    • View reference on PubMed
    • View reference on publisher's website
  23. Rattanaumpawan P, Lorsutthitham J, Ungprasert P, Angkasekwinai N, Thamlikitkul V (2010) Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. J Antimicrob Chemother 65:2645–2649
    • View reference on PubMed
    • View reference on publisher's website
  24. Kwa AL, Loh C, Low J, Kurup A, Tam VH (2005) Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 41:754–757
    • View reference on PubMed
    • View reference on publisher's website
  25. Kwa AL, Falagas ME, Michalopoulos A, Tam VH (2011) Benefits of aerosolized colistin for ventilator-associated pneumonia: absence of proof versus proof of absence? Clin Infect Dis 52:1278–1279
    • View reference on PubMed
    • View reference on publisher's website
  26. Linden PK, Paterson DL (2006) Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia. Clin Infect Dis 43:S89–S94
    • View reference on PubMed
    • View reference on publisher's website
  27. Dhand R, Duarte AG, Jubran A, Jenne JW, Fink JB, Fahey PJ, Tobin MJ (1996) Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med 154:388–393
    • View reference on PubMed
    • View reference on publisher's website
  28. Bernasconi M, Brandolese R, Poggi R, Manzin E, Rossi A (1990) Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction. Intensive Care Med 16:108–114
  29. Mouloudi E, Katsanoulas K, Anastasaki M, Hoing S, Georgopoulos D (1999) Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of tidal volume. Intensive Care Med 25:1215–1221
  30. Mouloudi E, Prinianakis G, Kondili E, Georgopoulos D (2001) Effect of inspiratory flow rate on beta2-agonist induced bronchodilation in mechanically ventilated COPD patients. Intensive Care Med 27:42–46
  31. Choudhry NK, Fletcher RH, Soumerai SB (2005) Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med 142:260–273
    • View reference on PubMed
    • View reference on publisher's website
  32. Malliotakis P, Linardakis M, Gavriilidis G, Georgopoulos D (2008) Duration of salmeterol-induced bronchodilation in mechanically ventilated chronic obstructive pulmonary disease patients: a prospective clinical study. Crit Care 12:R140
    • View reference on PubMed
    • View reference on publisher's website
  33. Guerin C, Chevre A, Dessirier P, Poncet T, Becquemin MH, Dequin PF, Le Guellec C, Jacques D, Fournier G (1999) Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:1036–1042
    • View reference on PubMed
    • View reference on publisher's website
  34. Dhand R, Tobin MJ (1996) Bronchodilator delivery with metered-dose inhalers in mechanically-ventilated patients. Eur Respir J 9:585–595
    • View reference on PubMed
    • View reference on publisher's website
  35. Mercier E, Dequin PF, Vecellio L (2008) Aerosols during mechanical ventilation. Rev Mal Respir 25:731–741
    • View reference on PubMed
    • View reference on publisher's website
  36. Davies JBS, Bromilow J (2011) Bacterial filter obstruction with the use of ultrasonic nebulisation. Anaesthesia 66:394–395
    • View reference on PubMed
    • View reference on publisher's website
  37. Laube BL, Janssens HM, de Jongh FHC, Devadason SG, Dhand R, Diot P, Everard ML, Horvath I, Navalesi P, Voshaar T, Chrystyn H (2011) ERS/ISAM task force consensus statement. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 37:1308–1331
    • View reference on PubMed
    • View reference on publisher's website
  38. Dolovich MA, MacIntyre NR, Anderson PJ, Camargo CA, Chew N, Cole CH, Dhand R, Fink JB, Gross NJ, Hess DR, Hickey AJ, Kim CS, Martonen TB, Pierson DJ, Rubin BK, Smaldone GC (2000) Consensus statement: aerosols and delivery devices. American Association for Respiratory Care. Respir Care 45:589–596
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement